Prostate cancer 3+4 vs 4+3

Diagnosis A doctor will carry out a physical examination and enquire about any ongoing medical history. If the patient has symptoms, or if a routine blood test shows abnormally high PSA levels, further examinations prostate cancer 3+4 vs 4+3 may be requested. Imaging scans prostate cancer 3+4 vs 4+3 can show and track the presence of prostate cancer. Imaging scans can show and track the presence of prostate cancer. Tests may include: a digital rectal examination (DRE), in which a doctor will manually check for any abnormalities of the prostate with their finger a biomarker test checking the blood, urine, Prostate cancer 3+4 vs 4+3 or body tissues of a person with cancer for chemicals Prostate cancer 3+4 vs 4+3 unique to individuals with cancer If these tests show abnormal Prostate cancer 3+4 vs 4+3 results, further tests will include: a PCA3 test Examining the urine for the PCA3 gene only found in prostate cancer cells a transrectal ultrasound scan providing imaging of the affected Prostate cancer 3+4 vs 4+3 region using a probe that emits sounds a biopsy, or the removal of 12 to 14 small pieces of tissue from several areas of the prostate for examination under a microscope prostate cancer 3+4 vs 4+3 These will help confirm the stage of the cancer, whether it has spread, and what treatment is appropriate. To track any spread, or metastasis, doctors may use a bone, CT scan, or MRI scan. Outlook If the disease is found before it spreads to other organs in a process known as metastasis, the 5-year survival rate is 99 percent. Once the cancer metastasizes, or spreads, the 5-year survival rate is 29 percent. Regular screening can help detect prostate cancer while it is still treatable. Risk factors Prostate cancer 3+4 vs 4+3 The exact cause of prostate cancer is unclear, but there are many possible risk factors. Age Prostate cancer is rare among men under the age of 45 years, but more common after the age of 50 years. Geography Prostate cancer occurs most frequently in North America, northwestern Europe, on the Caribbean islands, and in Australia. Genetic prostate cancer 3+4 vs 4+3 factors Certain genetic and ethnic groups have an increased risk of prostate cancer. In the U. S., prostate cancer is Prostate cancer 3+4 vs 4+3 at least 60 percent more common and 2 to 3 times more deadly among black Prostate cancer 3+4 vs 4+3 men than non-Hispanic white men.

A prostate cancer 3+4 vs 4+3 man also has a Prostate cancer 3+4 vs 4+3 much higher risk of developing cancer if his identical twin has it, and a man whose brother or father had prostate cancer has twice the risk of developing it compared to other men. Having a brother who has or has had prostate cancer is more of a genetic risk than having Prostate cancer 3+4 vs 4+3 a father with the disease. Diet Studies have suggested that a diet high in red meat or high-fat dairy products may increase a person's chances of developing prostate cancer, but the link is neither confirmed nor clear. Medication Some research has suggested that non-steroidal anti-inflammatory prostate cancer 3+4 vs 4+3 drug (NSAID) use may reduce the risk of prostate cancer. Others have linked NSAID use with a higher risk of death from the disease. This is a controversial area, and results have not been confirmed. There has also been some investigation into whether statins might prostate cancer 3+4 vs 4+3 slow the progression of prostate cancer.





Prostata cancer sintomas

Stage 2 prostate cancer treatment

Adrenal adenoma 3 cm

Prostata 16 cc

Prostate cancer treatment 7 news

15.04.2018 - DangeR

Causes the "seeds" including risk factors, symptoms, how.

15.04.2018 - QANQSTER

Diagnosis and treatment urinating needing to urinate more.

Cilexin